Llwytho...
Promising therapies for treatment of nonalcoholic steatohepatitis
INTRODUCTION: Non-alcoholic fatty liver disease (NAFLD) has become the most common etiology for abnormal aminotransferase levels and chronic liver disease. Its growing prevalence is largely linked to the presence of metabolic syndrome, particularly diabetes and insulin resistance. It is estimated th...
Wedi'i Gadw mewn:
| Cyhoeddwyd yn: | Expert Opin Emerg Drugs |
|---|---|
| Prif Awduron: | , , |
| Fformat: | Artigo |
| Iaith: | Inglês |
| Cyhoeddwyd: |
2016
|
| Pynciau: | |
| Mynediad Ar-lein: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5906104/ https://ncbi.nlm.nih.gov/pubmed/27501374 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1080/14728214.2016.1220533 |
| Tagiau: |
Ychwanegu Tag
Dim Tagiau, Byddwch y cyntaf i dagio'r cofnod hwn!
|